February , 2019

Email This Post Email This Post

The New Cancer Drug Nobody Can Afford: Sign The Petition

Posted by Admin On October - 13 - 2014
Care2 Petitions Action Alert
Action Alert!

Roche pharmaceuticals has put a value on the lives of cancer sufferers like my niece — $117,600. This cost is so high that even many insured patients can never get the drug!
Please sign the petition today! Roche: Stop Denying Treatment to Breast Cancer Sufferers!

Take Action
please share

it helps!
Share on Facebook Share on Twitter Share via Email

Shortly after my niece died, her five-year-old son told me that all he wanted for Christmas was, “Just one thing, Auntie Margaret: Five minutes with my mummy.”

It broke my heart — his wonderful mummy Helen had suffered an awful death from late-diagnosed breast cancer. At that time there were not many drugs that could have helped her. Now there is a new drug that could help people like my niece live longer, but manufacturer Roche is putting profits first, refusing to make the medicine affordable for most of those patients – and for the most horrible reason!

When asked why the drug was so expensive, Roche’s head of pricing callously said it reflects the value of the drug to the consumer. That almost sounds like Roche is saying life has a price, and if you can’t pay the price, you don’t deserve the product!

I started a Care2 petition demanding that Roche’s CEO reduce the cost of this drug and stop leaving cancer sufferers to die. Will you sign it?

I know exactly what it’s like to rely on necessary treatment for a life-threatening illness. Four and a half years ago, I was also diagnosed with breast cancer. I was lucky – my cancer was caught early, and I had access to a drug that cost just pennies and saved my life.

But thousands of women like my niece are diagnosed with aggressive, advanced-stage cancer. And instead of helping these people in need, Roche is putting profit first and asking $117,600 per year for the treatment. This price makes it far out of reach for many of the people who need it.

Roche made nearly $12 billion in profits last year. It’s unconscionable that this company would play with peoples’ lives like this to pad those profits even more.

Please join me to call on Roche to reduce the price of KADCYLA to a level that will make it available to people in need. Every corporation hates bad publicity — if 10,000 more of us sign the petition, Roche will have to take notice!


Thank you for taking action,

Margaret Connolly
Care2 Member

You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.

Recent Comments

Welcome to CopyLine Magazine! The first issue of CopyLine Magazine was published in November, 1990, by Editor & Publisher Juanita Bratcher. CopyLine’s main focus is on the political arena – to inform our readers and analyze many of the pressing issues of the day - controversial or otherwise. Our objectives are clear – to keep you abreast of political happenings and maneuvering in the political arena, by reporting and providing provocative commentaries on various issues. For more about CopyLine Magazine, CopyLine Blog, and CopyLine Television/Video, please visit juanitabratcher.com, copylinemagazine.com, and oneononetelevision.com. Bratcher has been a News/Reporter, Author, Publisher, and Journalist for 33 years. She is the author of six books, including “Harold: The Making of a Big City Mayor” (Harold Washington), Chicago’s first African-American mayor; and “Beyond the Boardroom: Empowering a New Generation of Leaders,” about John Herman Stroger, Jr., the first African-American elected President of the Cook County Board. Bratcher is also a Poet/Songwriter, with 17 records – produced by HillTop Records of Hollywood, California. Juanita Bratcher Publisher

Recent Posts